<DOC>
	<DOCNO>NCT00799084</DOCNO>
	<brief_summary>To improve management symptom , patient cancer undergo chemotherapy monitor use automate telephone system record severity 15 prevalent symptom 8 consecutive week . Outcomes include ; significant reduction symptom severity improvement health state .</brief_summary>
	<brief_title>Automated Telephone Monitoring Symptom Management</brief_title>
	<detailed_description>Overview : Prevalent symptom among patient undergo chemotherapy include : pain , fatigue , dry mouth , constipation , anorexia , nausea , sleep disturbance , shortness breath difficulty breathing , well psychological symptom depression anxiety . A survey 1000 patient cancer indicate close quarter report 10-12 symptom . Given impact symptom upon physical function , work , emotional distress , hospitalization , critical strategy develop test improve symptom management . This trial behavioural intervention symptom management significant : 1 ) contrast proactive approach , individualized patient ' symptom management need , conventional model place responsibility patient symptom management ; 2 ) control method delivery use print material ; 3 ) target prevalent symptom know affect cancer patient undergoing chemotherapy ; 4 ) examines relative effect arm , term symptom severity ( primary outcome ) , impact patient ' physical social role , emotional distress ; 5 ) explore outcomes term impact use service cost care . Goal : The goal randomize trial determine nurse deliver Patient Assisted Management Symptoms ( PAMS ) intervention individualize patient ' need symptom management , deliver telephone , compare Telephone Information Monitoring Symptoms ( TIMS ) symptom monitor telephone , reference symptom management toolkit reduce symptom severity , improve physical function , outcome .</detailed_description>
	<criteria>21 year age old solid tumor cancer diagnosis receive chemotherapy treatment Emotional psychology disorder patient receive treatment speak English access telephone difficulty hear telephone</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>symptom management</keyword>
	<keyword>cancer</keyword>
	<keyword>chemotherapy treatment</keyword>
	<keyword>Behavioral Research</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Clinical Trial , Phase II</keyword>
</DOC>